Cardioteva 75mg x 56 tablets

Cardioteva 75 mg contains the active ingredient acetylsalicylic acid. This medicine is indicated in adults as a means of reducing the risk of blood clots and, consequently, preventing heart attacks and strokes.

Composition of Cardioteva 75mg:

The active substance; acetylsalicylic acid (Acidum acetylsalicylicum). Each gastro-resistant tablet contains 75 mg of acetylsalicylic acid and the active substances: tablet core - microcrystalline cellulose, corn starch, colloidal anhydrous silica, stearic acid; tablet coating - methacrylic acid and ethyl acrylate copolymer (1: 1), polysorbate 80, sodium lauryl sulfate, triethyl citrate, talc.

Action of Cardioteva 75mg:

Acetylsalicylic acid is an active substance that acts as an antiplatelet drug when taken in low doses. Cardioteva 75 mg is indicated for the minimization of the risk of blood clots forming. The consequence of a blood clot can be a heart attack, angina or a stroke. Taking Cardioteva 75mg reduces the risk of blood clots and thus prevents heart attacks, strokes and cardiovascular problems in people who suffer from stable or unstable angina. In addition, the drug can be used as a preventative measure for blood clots following heart surgery to dilate or unblock blood vessels.

Cardioteva Application:
Cardioteva 75 mg indicated for use in the reduction of the risk of the formation of heart clots. Drug for prophylactic use.

Additional information:
Store the product out of reach of children, at room temperature. It is recommended to protect against moisture and light. People who are scheduled to have any surgery must inform their doctor that they are taking acetylsalicylic acid. Acetylsalicylic acid administered to children may cause Rey's syndrome, so the drug should not be used in children and adolescents under 16 years of age (unless your doctor tells you otherwise). The drug is not suitable for use as an antipyretic or analgesic, or for reliever use. Do not drink alcohol while taking the drug, as it may increase the risk of gastrointestinal bleeding and prolong bleeding time. Use of the drug during pregnancy and breastfeeding: it is not recommended to use the drug during pregnancy, unless otherwise prescribed by the doctor, the use of the drug is contraindicated in the third trimester; It is not recommended to use the drug during breastfeeding, unless your doctor tells you otherwise. This medicine contains sodium: less than 1mmol sodium (23mg) per tablet, so it can be considered 'sodium free'.

Contraindications:
Do not use in case of hypersensitivity to any component of the drug, to other salicylates, other non-steroidal anti-inflammatory drugs. Do not use in the event of an attack of bronchial asthma or swelling of certain parts of the body (angioedema) after taking salicylates or non-steroidal anti-inflammatory drugs. Do not use if you have or have had ulcers in the stomach or duodenum or any other type of bleeding (e.g. stroke). Do not use in case of problems with blood clotting. Do not use in case of severe liver or kidney problems. Do not use in the last trimester of pregnancy. Do not use simultaneously with methotrexate (used in doses of 15 mg per week or higher).

Side effects:
Some people may experience side effects during treatment. If you experience the following symptoms, stop taking this medicine immediately and contact your doctor: sudden wheezing when breathing, swelling of the lips, face or body, rash, tiredness or difficulty swallowing (severe allergic reactions), reddening of the skin with blisters or peeling that may be associated with high fever and joint pain (this could be erythema multiforme, Stevens-Johnson syndrome or Lyell's syndrome), unusual bleeding (e.g. coughing up blood, vomiting blood, blood in the urine, tarry stools). Common side effects: indigestion, increased bleeding tendency; uncommon: hives, runny nose, breathing difficulties; rare: heavy bleeding in the stomach or intestines, bleeding in the brain; changes in the number of blood cells in the blood, nausea and vomiting, spasm of the lower respiratory tract, asthma attack, inflammation of blood vessels, bruising with purple spots (bleeding in the skin), severe allergic reactions (erythema multiforme, Stevens-Johnson syndrome, Lyell's syndrome), hypersensitivity (swelling of e.g. lips, face or body, or shock), abnormal, heavy or prolonged menstrual periods; Not known: ringing in the ears (tinnitus) or decreased hearing, headache, dizziness, gastric or duodenal ulceration and perforation, prolonged bleeding time, impaired kidney function, impaired liver function, high levels of uric acid in the blood. bruising with purple spots (skin bleeding), severe allergic reactions (erythema multiforme, Stevens-Johnson syndrome, Lyell's syndrome), hypersensitivity reactions (swelling e.g. of the lips, face or body, or shock), abnormal, heavy or prolonged menstrual bleeding ; Not known: ringing in the ears (tinnitus) or decreased hearing, headache, dizziness, gastric or duodenal ulceration and perforation, prolonged bleeding time, impaired kidney function, impaired liver function, high levels of uric acid in the blood. bruising with purple spots (skin bleeding), severe allergic reactions (erythema multiforme, Stevens-Johnson syndrome, Lyell's syndrome), hypersensitivity reactions (swelling e.g. of the lips, face or body, or shock), abnormal, heavy or prolonged menstrual bleeding ; Not known: ringing in the ears (tinnitus) or decreased hearing, headache, dizziness, gastric or duodenal ulceration and perforation, prolonged bleeding time, impaired kidney function, impaired liver function, high levels of uric acid in the blood.

Dosage of Cardioteva 75 mg tablets:

Use as directed by your doctor or according to the directions on the leaflet. Swallow the tablet whole (do not chew, chew, crush or break it), drink it with water (about half a glass). In adults - prevention of heart attacks: 75-160 mg once a day; prevention of strokes: 75-325 mg once daily; prevention of cardiovascular problems in patients who suffer from stable or unstable angina: 75-160 mg once a day; prevention of blood clots after certain heart surgery: 75-160 mg once daily. Elderly patients do not require dose adjustments, but caution should be exercised as the elderly are more prone to developing side effects. Treatment effects should be reassessed at regular intervals. Adolescents and children under 16 years of age